glycylglutamine has been researched along with 3,4-dihydroxyphenylacetic acid in 1 studies
| Studies (glycylglutamine) | Trials (glycylglutamine) | Recent Studies (post-2010) (glycylglutamine) | Studies (3,4-dihydroxyphenylacetic acid) | Trials (3,4-dihydroxyphenylacetic acid) | Recent Studies (post-2010) (3,4-dihydroxyphenylacetic acid) |
|---|---|---|---|---|---|
| 104 | 8 | 14 | 5,410 | 38 | 591 |
| Protein | Taxonomy | glycylglutamine (IC50) | 3,4-dihydroxyphenylacetic acid (IC50) |
|---|---|---|---|
| intestinal alkaline phosphatase precursor | Mus musculus (house mouse) | 4.17 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basaran, NF; Buyukuysal, RL; Cavun, S; Millington, WR | 1 |
1 other study(ies) available for glycylglutamine and 3,4-dihydroxyphenylacetic acid
| Article | Year |
|---|---|
Glycyl-glutamine (beta-endorphin(30-31)) inhibits morphine-induced dopamine efflux in the nucleus accumbens.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analgesics, Opioid; Animals; Dipeptides; Dopamine; Dose-Response Relationship, Drug; Male; Microdialysis; Morphine; Nucleus Accumbens; Rats; Rats, Sprague-Dawley; Reward; Time Factors | 2010 |